- Report
- April 2022
- 40 Pages
Vietnam
From €1424EUR$1,500USD£1,201GBP
- Report
- April 2022
- 40 Pages
Brazil
From €1424EUR$1,500USD£1,201GBP
- Report
- April 2022
- 40 Pages
China
From €1424EUR$1,500USD£1,201GBP
- Report
- April 2022
- 40 Pages
France
From €1424EUR$1,500USD£1,201GBP
- Report
- December 2023
- 61 Pages
Global
From €14235EUR$14,995USD£12,008GBP
- Report
- December 2022
- 99 Pages
Global
From €1899EUR$2,000USD£1,602GBP
- Report
- September 2024
- 89 Pages
Global
From €3500EUR$3,949USD£3,056GBP
- Report
- August 2024
- 86 Pages
Global
From €3500EUR$3,949USD£3,056GBP
- Report
- June 2023
- 91 Pages
Global
From €3500EUR$3,949USD£3,056GBP
The Female Contraceptive market is an important part of Women's Health, providing women with the ability to control their reproductive health. Contraceptives are used to prevent pregnancy, and can be divided into two main categories: hormonal and non-hormonal. Hormonal contraceptives, such as the pill, patch, and ring, use hormones to prevent ovulation and fertilization. Non-hormonal contraceptives, such as condoms, diaphragms, and spermicides, work by blocking sperm from entering the uterus.
In addition to preventing pregnancy, contraceptives can also be used to treat a variety of conditions, such as endometriosis, polycystic ovary syndrome, and acne. Contraceptives can also be used to regulate menstrual cycles and reduce the risk of certain cancers.
Some companies in the Female Contraceptive market include Bayer, Merck, Pfizer, and Teva Pharmaceuticals. Show Less Read more